Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2025-07-23 13:16:20| The Economic Times

Dr Reddy's Laboratories Q1 Results: Pharma major Dr. Reddy's Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418 crore for the first quarter ended June. Revenue from operations rose 11% YoY to Rs 8,545 crore.


Category: News and Media

 

LATEST NEWS

2025-07-23 12:03:43| BBC News | Business | World Edition

Thomas Woldbye said it wasn't normally the way he acted as a power outage disrupted 1,300 flights.


Category: News and Media

 

2025-07-23 12:00:58| Chicago Tribune news - Business

Cuts outlined in President Donald Trumps proposed 2026 budget mean some groups stand to lose federal funds that support services like testing and HIV treatment.


Category: News and Media

 

Latest from this category

25.07Ashish Kacholia-backed Shree Refrigerations IPO opens with 64% GMP. Check all details
25.07Positive Breakout: These 9 stocks cross above their 200 DMAs
25.07Asian stocks snap six days of gains, bonds steady
25.07SBI General says it gained private cos' market share
25.07Bajaj Finance's Rajeev Jain given six months to develop succession plan after leadership change
25.07Chemical companies to post 5-10% revenue growth in Q1 amid tariff concerns, weaker rupee
25.07Goldman goes 'Neutral' on Trent, stock declines 4%
25.07US FCC clears $8bn Skydance-Paramount merger
News and Media »

All news

25.07Friday Watch
25.07Ashish Kacholia-backed Shree Refrigerations IPO opens with 64% GMP. Check all details
25.07Positive Breakout: These 9 stocks cross above their 200 DMAs
25.07Asian stocks snap six days of gains, bonds steady
25.07SBI General says it gained private cos' market share
25.07Bajaj Finance's Rajeev Jain given six months to develop succession plan after leadership change
25.07Chemical companies to post 5-10% revenue growth in Q1 amid tariff concerns, weaker rupee
25.07Goldman goes 'Neutral' on Trent, stock declines 4%
More »
Privacy policy . Copyright . Contact form .